These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37539698)

  • 1. Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study.
    Dachs LR; Gaisán CM; Bustamante G; López SG; García EG; Persona EP; González-Calle V; Auzmendi MS; Pérez JMA; González Montes Y; Ríos Tamayo R; de Miguel Llorente D; Bernal LP; Mayol AS; Caro CC; Grande M; Fernández-Nistal A; Naves A; Miguel EMOS
    Leuk Lymphoma; 2023; 64(11):1847-1856. PubMed ID: 37539698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20.
    Ahmadzadeh A; Yekaninejad MS; Saffari M; Pakpour AH; Aaronson NK
    Asian Pac J Cancer Prev; 2016; 17(1):255-9. PubMed ID: 26838220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the European Organisation for Research and Treatment of Cancer multiple myeloma module (EORTC QLQ-MY20): a review of the literature 25 years after development.
    Forde K; Cocks K; Wells JR; McMillan I; Kyriakou C;
    Blood Cancer J; 2023 May; 13(1):79. PubMed ID: 37193682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma.
    Malta JS; Silveira LP; Drummond PLM; Costa NL; Dos Santos RMM; Reis IA; Reis AMM; de Pádua CAM
    Curr Med Res Opin; 2021 Jul; 37(7):1163-1169. PubMed ID: 33979261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument.
    Espinoza-Zamora JR; Portilla-Espinosa CM; Labardini-Méndez JR; Cervera E; Niesvisky R; Oñate-Ocaña LF
    Ann Hematol; 2015 Jun; 94(6):1017-24. PubMed ID: 25563595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Quality of Life Multiple Myeloma Module Questionnaire (QLQ-MY20) in Portuguese myeloma patients.
    Graça Pereira M; Ferreira G; Pereira M; Faria S; Bacalhau R; Monteiro S; Fernandes B; Vilaça M
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13128. PubMed ID: 31273859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma.
    Kontodimopoulos N; Samartzis A; Papadopoulos AA; Niakas D
    ScientificWorldJournal; 2012; 2012():842867. PubMed ID: 22919356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
    Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
    Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
    Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
    Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M
    Health Qual Life Outcomes; 2018 Jun; 16(1):127. PubMed ID: 29914509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of the Chilean version of the quality of life questionnaire for multiple myeloma.
    Lorca LA; Sacomori C; Peña C; Barrera C; Salazar M; Leão I; Valladares X; Rojas C
    Rev Bras Enferm; 2024; 77(1):e20230100. PubMed ID: 38716906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S; Jayasekara P; Abeysinghe P; Hjermstad M; Lalloo R
    BMC Oral Health; 2022 Aug; 22(1):359. PubMed ID: 35986341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires.
    Ficko SL; Pejsa V; Zadnik V
    Radiol Oncol; 2019 Sep; 53(3):337-347. PubMed ID: 31553711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of the Urdu version of the EORTC QLQ-H&N35 (European organization for research and treatment of cancer head and neck module) quality of life tool.
    Zahid N; Martins RS; Zahid W; Azam I; Ikram M; Hassan A; Bhamani SS; Jabbar AA; Asad N; Akhtar S; Siddiqui MI; Awan MS; Ahmad K
    BMC Psychol; 2022 Aug; 10(1):194. PubMed ID: 35934706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France.
    Despiégel N; Touboul C; Flinois A; Saba G; Suzan F; Gonzalez-McQuire S; Bonnetain F
    Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e13-e28. PubMed ID: 30292736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
    Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.